Physitrack PLC (PTRK) - Total Liabilities

Latest as of February 2026: Skr8.74 Million SEK ≈ $940.78K USD

Based on the latest financial reports, Physitrack PLC (PTRK) has total liabilities worth Skr8.74 Million SEK (≈ $940.78K USD) as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Physitrack PLC net asset momentum to track the company's year-over-year net asset growth rate.

Physitrack PLC - Total Liabilities Trend (2014–2025)

This chart illustrates how Physitrack PLC's total liabilities have evolved over time, based on quarterly financial data. See PTRK free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Physitrack PLC Competitors by Total Liabilities

The table below lists competitors of Physitrack PLC ranked by their total liabilities.

Company Country Total Liabilities
Salona Cotspin Limited
NSE:SALONA
India Rs2.20 Billion
MSCM Holdings Bhd
KLSE:0041
Malaysia RM78.65 Million
Euromedis Groupe SA
PA:ALEMG
France €23.04 Million
ESV Inc
KQ:223310
Korea ₩54.18 Billion
Image Resources NL
AU:IMA
Australia AU$120.74 Million
Priceworth International Bhd
KLSE:7123
Malaysia RM149.37 Million
Minnova Corp
V:MCI
Canada CA$4.94 Million
Argenica Therapeutics Ltd
AU:AGN
Australia AU$1.76 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Physitrack PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PTRK stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.44 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Physitrack PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Physitrack PLC (2014–2025)

The table below shows the annual total liabilities of Physitrack PLC from 2014 to 2025.

Year Total Liabilities Change
2025-11-30 Skr9.23 Million
≈ $993.82K
-18.56%
2024-11-30 Skr11.34 Million
≈ $1.22 Million
-13.64%
2023-11-30 Skr13.13 Million
≈ $1.41 Million
-30.68%
2022-11-30 Skr18.94 Million
≈ $2.04 Million
+421.90%
2021-11-30 Skr3.63 Million
≈ $390.59K
-46.33%
2020-11-30 Skr6.76 Million
≈ $727.80K
+751.08%
2019-11-30 Skr794.63K
≈ $85.52K
-4.51%
2018-11-30 Skr832.14K
≈ $89.55K
+56.06%
2017-11-30 Skr533.23K
≈ $57.38K
+3.49%
2016-11-30 Skr515.26K
≈ $55.45K
+763.73%
2015-11-30 Skr59.66K
≈ $6.42K
-67.53%
2014-11-30 Skr183.73K
≈ $19.77K
--

About Physitrack PLC

ST:PTRK Sweden Health Information Services
Market Cap
$14.10 Million
Skr131.06 Million SEK
Market Cap Rank
#26140 Global
#548 in Sweden
Share Price
Skr8.06
Change (1 day)
-1.23%
52-Week Range
Skr7.36 - Skr21.00
All Time High
Skr70.00
About

Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehe… Read more